Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mariko Ogura
Observed names:
M. Ogura,
MARIKO OGURA,
Ogura Mariko,
Ogura, Mariko
Institutions:
The Cancer Institute Hospital,
Japanese Foundation For Cancer Research
Observed institutions:
Keio University,
Fudan University,
Toho University Omori Medical Center,
Zhongshan Hospital,
Aichi Cancer Center,
The Cancer Institute Hospital,
Gifu University,
Japanese Foundation For Cancer Research,
Aichi Cancer Center Hospital
show all 9
ORCID:
0000-0002-1004-8425
Observed ORCID:
0000-0002-1004-8425
OpenAlex ID:
A5077085235
Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START)
2013
·
The JACCRO and KCSG Study Group
, Wasaburo Koizumi
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
184
PDF
Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer
2010
·
Satoshi Matsusaka
, Keisho Chìn
, et al.
·
Cancer Science
·
127
PDF
Clinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer
2018
·
Takeru Wakatsuki
, Noriko Yamamoto
, et al.
·
Journal of Gastroenterology
·
118
PDF
Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer
2018
·
Shusuke Yagi
, Takeru Wakatsuki
, et al.
·
Gastric Cancer
·
81
PDF
Phase II study of reintroduction of oxaliplatin for advanced colorectal cancer in patients previously treated with oxaliplatin and irinotecan: RE-OPEN study
2015
·
Mitsukuni Suenaga
, Nobuyuki Mizunuma
, et al.
·
Drug Design Development and Therapy
·
74
PDF
Changes in the neutrophil-to-lymphocyte ratio during nivolumab monotherapy are associated with gastric cancer survival
2020
·
Yumiko Ota
, Daisuke Takahari
, et al.
·
Cancer Chemotherapy and Pharmacology
·
73
Safety and pharmacokinetics of milademetan, a MDM2 inhibitor, in Japanese patients with solid tumors: A phase I study
2021
·
Shunji Takahashi
, Yutaka Fujiwara
, et al.
·
Cancer Science
·
66
PDF
Detection of HER2 Amplification in Circulating Tumor Cells of HER2-Negative Gastric Cancer Patients
2017
·
Yuji Mishima
, Satoshi Matsusaka
, et al.
·
Targeted Oncology
·
46
Neoadjuvant Chemoradiotherapy with Cisplatin Plus Fluorouracil for Borderline Resectable Esophageal Squamous Cell Carcinoma
2019
·
Takeshi Suzuki
, Akihiko Okamura
, et al.
·
Annals of Surgical Oncology
·
34
Long‐term outcomes of esophageal squamous cell carcinoma with invasion depth of pathological T1a‐muscularis mucosae and T1b‐submucosa by endoscopic resection followed by appropriate additional treatment
2021
·
Sakiko Naito
, Toshiyuki Yoshio
, et al.
·
Digestive Endoscopy
·
30
Incidence, clinicopathological features, and clinical outcomes of low HER2 expressed, inoperable, advanced, or recurrent gastric/gastroesophageal junction adenocarcinoma
2023
·
I. Nakayama
, D. Takahari
, et al.
·
ESMO Open
·
27
PDF
Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients
2017
·
Izuma Nakayama
, Eiji Shinozaki
, et al.
·
BMC Cancer
·
26
PDF
Correlation between circulating tumor DNA and carcinoembryonic antigen levels in patients with metastatic colorectal cancer
2021
·
Hiroki Osumi
, Eiji Shinozaki
, et al.
·
Cancer Medicine
·
25
PDF
Non‐V600E BRAF mutations and EGFR signaling pathway in colorectal cancer
2019
·
Hiroki Osumi
, Eiji Shinozaki
, et al.
·
International Journal of Cancer
·
25
PDF
Associations between early tumor shrinkage and depth of response and clinical outcomes in patients treated with 1st-line chemotherapy for advanced gastric cancer
2017
·
Hiroki Osumi
, Daisuke Takahari
, et al.
·
Gastric Cancer
·
24
PDF
Managing zolbetuximab-induced nausea and vomiting: a proposal for a pragmatic approach in clinical practice
2025
·
K. Shimozaki
, A. Ooki
, et al.
·
ESMO Gastrointestinal Oncology
·
22
PDF
KRAS mutation as a predictor of insufficient trastuzumab efficacy and poor prognosis in HER2-positive advanced gastric cancer
2022
·
Keitaro Shimozaki
, Eiji Shinozaki
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
21
Cetuximab treatment for metastatic colorectal cancer with KRAS p.G13D mutations improves progression-free survival
2015
·
HIROKI OSUMI
, EIJI SHINOZAKI
, et al.
·
Molecular and Clinical Oncology
·
21
PDF
Effect of neutropenia on survival outcomes of patients with metastatic colorectal cancer receiving trifluridine/tipiracil plus bevacizumab
2021
·
Daisaku Kamiimabeppu
, Hiroki Osumi
, et al.
·
Oncology Letters
·
20
PDF
Clinical Impact of Primary Tumor Location andRAS, BRAFV600E, andPIK3CAMutations on Epidermal Growth Factor Receptor Inhibitor Efficacy as Third-line Chemotherapy for Metastatic Colorectal Cancer
2021
·
TARO SATO
, HIROKI OSUMI
, et al.
·
Anticancer Research
·
20
PDF
Early hypertension and neutropenia are predictors of treatment efficacy in metastatic colorectal cancer patients administered FOLFIRI and vascular endothelial growth factor inhibitors as second‐line chemotherapy
2020
·
Hiroki Osumi
, Eiji Shinozaki
, et al.
·
Cancer Medicine
·
20
PDF
Failure of neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma
2017
·
A. Okamura
, M. Watanabe
, et al.
·
Diseases of the Esophagus
·
20
A multi-institutional observational study evaluating the incidence and the clinicopathological characteristics of NeoRAS wild-type metastatic colorectal cancer
2023
·
Hiroki Osumi
, Atsuo Takashima
, et al.
·
Translational Oncology
·
18
Clinical Progress in Inoperable or Recurrent Advanced Gastric Cancer Treatment from 1004 Single Institute Experiences Between 2007 and 2018
2022
·
Izuma Nakayama
, Daisuke Takahari
, et al.
·
The Oncologist
·
18
A novel clinical prognostic index for patients with advanced gastric cancer: possible contribution to the continuum of care
2021
·
K. Shimozaki
, I. Nakayama
, et al.
·
ESMO Open
·
18
Show more works
View as search
Works count:
214
Citation count:
1,705
H-index:
20
I10-index:
45
Year
Topic
Type